Micrus Endovascular To Present At March Investment Conferences

Main Category: Neurology / Neuroscience
Also Included In: Stroke / Neuroprotection;  Conferences
Article Date: 03 Mar 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Micrus Endovascular Corporation (Nasdaq: MEND) announced that management will make presentations at four investment conferences in March:

- Robert Stern, Micrus President and COO, will present at the Rodman & Renshaw "Straight to the Heart" one-day, one-on-one meeting conference on Tuesday, March 4. The conference will be held at the Boston Harbor Hotel.

- John Kilcoyne, Micrus Chairman and CEO, will present at the Susquehanna International Group's SIGnificant Options Healthcare Conference on Wednesday, March 5 at 2:00 p.m. Eastern time. This conference will be held at the W Hotel in New York.

- Robert Stern, Micrus President and COO, will present at the Cowen and Company 28th Annual Health Care Conference on March 18 at 11:00 a.m. Eastern time. This conference will be held at The Boston Marriott Copley Place.

- Gordon Sangster, Micrus CFO, will present at Citigroup's 5th Annual Small & Mid Cap Conference on Wednesday, March 19 at 8:05 a.m. Pacific time. This conference will be held at the Four Seasons hotel at Mandalay Bay in Las Vegas.

A live webcast of conference presentations at the Susquehanna International Group's SIGnificant Options Healthcare Conference, Citigroup's 5th Annual Small & Mid Cap Conference, and Cowen and Company 28th Annual Health Care Conference will be available via the Internet by visiting the Investor Relations section of Micrus' Web site at http://www.micruscorp.com. Each presentation will be archived and available on the Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms responsible for hemorrhagic stroke, a significant cause of death worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. Micrus' proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells accessory devices and products used in conjunction with its microcoils.

http://www.micruscorp.com